topstockalerts
Melius Research downgraded TransDigm from Buy to Hold and set a $1,330 price target, removing one of the stock’s more bullish analyst voices as shares face sustained pressure. The downgrade coincided with the company announcing plans for a $2.5 billion private placement of senior secured notes, with proceeds intended to fully repay its 6.75% senior secured notes due in 2028 through a concurrent tender offer.
While the refinancing is designed to extend TransDigm’s debt maturity profile, the size of the transaction renewed concerns about its elevated leverage. Shares are now more than 24% below their 52-week high of $1,463.03, while analyst sentiment has shifted to 13 Buy ratings, 9 Holds and no Sells.
$TDG
